DrugBiological

Trastuzumab mafodotin clinical trials

studies test it: 3
open now: 2
in phase 3: 1
first study started: 2019

Keep track of what changes. Save the trastuzumab mafodotin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Studies by the year they started

3 studies that test it; most in 2023 (2)

Studies that test trastuzumab mafodotin, by start year
Year	Studies
2019	1
2023	2

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 3: 1

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms: 3

Who runs them

Industry 3 · Other 0

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (2) · Iksuda Therapeutics Ltd. (1)

Often tested with

Tested in the same studies.

Caxmotabart entudotin (3)

Related medicines

As reviewed, each with the page that says it.

One of Histamine Antagonists source

Studies

Open first, then newest update. How each study uses trastuzumab mafodotin is read from its arms, and is right about nine times in ten.

Testing it · 3

Codes

What other systems call trastuzumab mafodotin · ClinicalTrials.gg INT016602

UNII (FDA) FWA9E3VB3KTRASTUZUMAB MAFODOTINOne source FDA
NCI Thesaurus C218975Trastuzumab MafodotinOne source FDA

System	Code	Name there	Checked by
UNII (FDA)	FWA9E3VB3K	TRASTUZUMAB MAFODOTIN	One source FDA
NCI Thesaurus	C218975	Trastuzumab Mafodotin	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.